Unexplained fractures in infancy: looking for fragile bones
Related Articles
- A Review of Osteoporosis: Part I. Impact, Pathophysiology, Diagnosis and Unique Role of the Physiatrist Kasturi, Gopi C.; Cifu, David X.; Adler, Robert A. // PM & R: Journal of Injury, Function & Rehabilitation;Mar2009, Vol. 1 Issue 3, p254
Osteoporosis is characterized by decreased bone quantity and quality, leading to increased fracture risk. Despite important strides in understanding and treating this disorder, there is a large gap between knowledge and practice. In this first section of a 3-part review, the impact,...
- Ankylosing spondylitis in sub-Saharan Africa. Belachew, D. A.; Sandu, N.; Schaller, B.; Guta, Z. // Postgraduate Medical Journal;Jul2009, Vol. 85 Issue 1005, p5
Ankylosing spondylitis (AS) represents a chronic inflammatory bone disease of the axial skeleton that manifests as chronic back pain and progressive stiffness of the spine. It characteristically affects young adults with a peak age of onset between 20-30 years. In contrast to Western Europe and...
- Fracture of humerus during use of an arm wrestling machine. Helm, R.H.; Stuart, P. // British Medical Journal (Clinical Research Edition);12/20/1986, Vol. 293 Issue 6562, p1644
Reports the fracture of humerus during use of an arm wrestling machine. Description of the machine; Signs and symptoms of fracture of humerus; Mechanism of injury.
- Development and validation of a population-based prediction scale for osteoporotic fracture in the region of Valencia, Spain: the ESOSVAL-R study. Sanfélix-Genovés, José; Peiró, Salvador; Sanfélix-Gimeno, Gabriel; Giner, Vicente; Gil, Vicente; Pascual, Manuel; Fluixá, Carlos; Fuertes, Antonio; Hurtado, Isabel; Ferreros, Inmaculada // BMC Public Health;2010, Vol. 10 Issue 1, p153
Background: Today, while there are effective drugs that reduce the risk of osteoporotic fracture, yet there are no broadly accepted criteria that can be used to estimate risks and decide who should receive treatment. One of the actual priorities of clinical research is to develop a set of simple...
- Incidence of osteoporosis in men. // American Family Physician;6/1/1997, Vol. 55 Issue 8, p2852
Discusses the occurrence of osteoporosis and hip fracture among men published in the `Australian Family Physician,' dated February, 1997. Preventive measures of fractures; Related diseases; Treatment of diseases.
- OSTEOPOROSIS. Sahley, Billie J. // MMRC Health Educator Reports;2005, Special section p1
The article presents information on the etiology of osteoporosis. It has been estimated by the National Osteoporosis Foundation that about 28 million Americans have osteoporosis or low bone density. Until a fracture occurs, osteoporosis is usually asymptomatic. Symptoms of osteoporosis include...
- Excessive dynamic airway collapse for the internist: new nomenclature or different entity? Kalra, Ankur; Abouzgheib, Wissam; Gajera, Mithil; Palaniswamy, Chandrasekar; Puri, Nitin; Dellinger, Richard Phillip // Postgraduate Medical Journal;Jul2011, Vol. 87 Issue 1029, p482
Excessive dynamic airway collapse (EDAC) refers to abnormal and exaggerated bulging of the posterior wall within the airway lumen during exhalation. This condition is pathological if the reduced airway lumen is <50% of the normal. It is a relatively new disease entity that is recognised more...
- Chronic Recurrent Multifocal Osteomyelitis in Infancy: A Case Report. Sakran, Waheeb; Lumelsky, Dmitry; Schildkraut, Vered; Smolkin, Vladislav; Halevy, Raphael; Koren, Ariel // Clinical Pediatrics;Oct2003, Vol. 42 Issue 8, p741
Details the case of a 9-month-old infant diagnosed with chronic recurrent multifocal osteomyelitis. Presenting signs and symptoms; Diagnostic procedures; Clinical course; Radiographic findings; No response of the patient to antibiotics.
- Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. Hamdy, Neveen A.T.; Kanis, John A. // BMJ: British Medical Journal (International Edition);2/11/95, Vol. 310 Issue 6976, p358
Examines the efficacy and safety of alfacalcidol in the prevention of renal bone disease when used earlier in course of renal failure. Double blind, prospective, randomized, placebo controlled study of 176 patients aged 18-81; Quantitative histology of bone.
